II

106TH CONGRESS

2D SESSION S. 2731

To amend title III of the Public Health Service Act to enhance the Nation’s

capacity to address public health threats and emergencies.

IN THE SENATE OF THE UNITED STATES

JUNE 14, 2000

Mr. FRIST (for himself and Mr. KENNEDY) introduced the following bill;

which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend title III of the Public Health Service Act to

enhance the Nation’s capacity to address public health

threats and emergencies.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Public Health Threats

5 and Emergencies Act’’.
2

•S 2731 IS

1 SEC. 2. AMENDMENTS TO THE PUBLIC HEALTH SERVICE

2 ACT.

3 Part B of title III of the Public Health Service Act

4 (42 U.S.C. 243 et seq.) is amended by striking section

5 319 and inserting the following:

6 ‘‘SEC. 319. PUBLIC HEALTH EMERGENCIES.

7 ‘‘(a) EMERGENCIES.—If the Secretary determines,

8 after consultation with the Director of the Centers for Dis9 ease Control and Prevention and other public health offi10 cials as may be necessary, that—

11 ‘‘(1) a disease or disorder presents a public

12 health emergency; or

13 ‘‘(2) a public health emergency, including sig14 nificant outbreaks of infectious diseases or bioter15 rorist attacks, otherwise exists,

16 the Secretary may take such action as may be appropriate

17 to respond to the public health emergency, including mak18 ing grants and entering into contracts and conducting and

19 supporting investigations into the cause, treatment, or

20 prevention of a disease or disorder as described in para21 graphs (1) and (2).

22 ‘‘(b) PUBLIC HEALTH EMERGENCY FUND.—

23 ‘‘(1) IN GENERAL.—There is established in the

24 Treasury a fund to be designated as the ‘Public

25 Health Emergency Fund’ to be made available to

26 the Secretary without fiscal year limitation to carry
3

•S 2731 IS

1 out subsection (a) only if a public health emergency

2 has been declared by the Secretary under such sub3 section. There is authorized to be appropriated to

4 the Fund such sums as may be necessary.

5 ‘‘(2) REPORT.—Not later than 90 days after

6 the end of each fiscal year, the Secretary shall pre7 pare and submit to the Committee on Health, Edu8 cation, Labor, and Pensions of the Senate and the

9 Committee on Commerce of the House of Represent10 atives a report describing—

11 ‘‘(A) the expenditures made from the Pub12 lic Health Emergency Fund in such fiscal year;

13 and

14 ‘‘(B) each public health emergency for

15 which the expenditures were made and the ac16 tivities undertaken with respect to each emer17 gency which was conducted or supported by ex18 penditures from the Fund.

19 ‘‘(c) SUPPLEMENT NOT SUPPLANT.—Funds appro20 priated under this section shall be used to supplement and

21 not supplant other Federal, State, and local public funds

22 provided for activities under this section.

23 ‘‘SEC. 319A. NATIONAL NEEDS TO COMBAT THREATS TO

24 PUBLIC HEALTH.

25 ‘‘(a) CAPACITIES.—
4

•S 2731 IS

1 ‘‘(1) IN GENERAL.—Not later than 1 year after

2 the date of enactment of this section, the Secretary,

3 and such Administrators, Directors, or Commis4 sioners, as may be appropriate, and in collaboration

5 with State and local health officials, shall establish

6 reasonable capacities that are appropriate for na7 tional, State, and local public health systems and the

8 personnel or work forces of such systems. Such ca9 pacities shall be revised every 10 years, or more fre10 quently as the Secretary determines to be necessary.

11 ‘‘(2) BASIS.—The capacities established under

12 paragraph (1) shall improve, enhance or expand the

13 capacity of national, state and local public health

14 agencies to detect and respond effectively to signifi15 cant public health threats, including major out16 breaks of infectious disease, pathogens resistant to

17 antimicrobial agents and acts of bioterrorism. Such

18 capacities may include the capacity to—

19 ‘‘(A) recognize the clinical signs and epide20 miological characteristic of significant outbreaks

21 of infectious disease;

22 ‘‘(B) identify disease-causing pathogens

23 rapidly and accurately;

24 ‘‘(C) develop and implement plans to pro25 vide medical care for persons infected with dis-
5

•S 2731 IS

1 ease-causing agents and to provide preventive

2 care as needed for individuals likely to be ex3 posed to disease-causing agents;

4 ‘‘(D) communicate information relevant to

5 significant public health threats rapidly to local,

6 State and national health agencies; or

7 ‘‘(E) develop or implement policies to pre8 vent the spread of infectious disease or anti9 microbial resistance.

10 ‘‘(b) REPORT.—Not later than 1 year after the date

11 of enactment of this section, and every 10 years thereafter,

12 the Secretary shall prepare and submit to the Committee

13 on Health, Education, Labor, and Pensions of the Senate

14 and the Committee on Commerce of the House of Rep15 resentatives a report describing the capacities established

16 pursuant to subsection (a).

17 ‘‘(c) SUPPLEMENT NOT SUPPLANT.—Funds appro18 priated under this section shall be used to supplement and

19 not supplant other Federal, State, and local public funds

20 provided for activities under this section.

21 ‘‘(d) TECHNICAL ASSISTANCE.—The Secretary shall

22 provide technical assistance to the States to assist such

23 States in fulfilling the requirements of this section.

24 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There

25 is authorized to be appropriated to carry out this section
6

•S 2731 IS

1 such sums as may be necessary for each of the fiscal years

2 2001 through 2006.

3 ‘‘SEC. 319B. ASSESSMENT OF PUBLIC HEALTH NEEDS.

4 ‘‘(a) PROGRAM AUTHORIZED.—Not later than 1 year

5 after the date of enactment of this section and every 10

6 years thereafter, the Secretary shall award grants to

7 States to perform, in collaboration with local public health

8 agencies, an evaluation to determine the extent to which

9 States or local public health agencies can achieve the ca10 pacities applicable to State and local public health agen11 cies described in subsection (a) of section 319A. The Sec12 retary shall provide technical assistance to States in addi13 tion to awarding such grants.

14 ‘‘(b) PROCEDURE.—

15 ‘‘(1) IN GENERAL.—A State may contract with

16 an outside entity to perform the evaluation described

17 in subsection (a).

18 ‘‘(2) METHODS.—To the extent practicable, the

19 evaluation described in subsection (a) shall be com20 pleted by using commonly accepted methods.

21 ‘‘(c) REPORT BY STATE.—Not later than 1 year after

22 the date on which a State receives a grant under this sub23 section, such State shall prepare and submit to the Sec24 retary a report describing the results of the evaluation de25 scribed in subsection (a) with respect to such State.
7

•S 2731 IS

1 ‘‘(d) SUPPLEMENT NOT SUPPLANT.—Funds appro2 priated under this section shall be used to supplement and

3 not supplant other Federal, State, and local public funds

4 provided for activities under this section.

5 ‘‘(E) AUTHORIZATION OF APPROPRIATIONS.—There

6 is authorized to be appropriated to carry out this section

7 such sums as may be necessary for each of the fiscal years

8 2002 and 2003.

9 ‘‘SEC. 319C. GRANTS TO IMPROVE STATE AND LOCAL PUB10 LIC HEALTH AGENCIES.

11 ‘‘(a) PROGRAM AUTHORIZED.—The Secretary shall

12 award competitive grants to eligible entities to address

13 core public health capacity needs using the capacities de14 veloped under section 319A, with a particular focus on

15 building capacity to identify, detect, monitor, and respond

16 to threats to the public health.

17 ‘‘(b) ELIGIBLE ENTITIES.—A State or political sub18 division of a State, or a consortium of 2 or more States

19 or political subdivisions of States, that has completed an

20 evaluation under section 319B(a), or an evaluation that

21 is substantially equivalent as determined by the Secretary

22 under section 319B(a), shall be eligible for grants under

23 subsection (b).
8

•S 2731 IS

1 ‘‘(c) USE OF FUNDS.—An eligible entity that receives

2 a grant under subsection (b), may use funds received

3 under such grant to—

4 ‘‘(1) train public health personnel;

5 ‘‘(2) develop, enhance, coordinate, or improve

6 participation in an electronic network by which dis7 ease detection and public health related information

8 can be rapidly shared among national, regional,

9 State, and local public health agencies and health

10 care providers;

11 ‘‘(3) develop a plan for responding to public

12 health emergencies, including significant outbreaks

13 of infectious diseases or bioterrorism attacks, which

14 is coordinated with the capacities of applicable na15 tional, State, and local national health agencies; and

16 ‘‘(4) enhance laboratory capacity and facilities.

17 ‘‘(d) REPORT.—Not later than 1 year after the date

18 of enactment of this section and annually thereafter, the

19 Secretary shall prepare and submit to the Committee on

20 Health, Education, Labor, and Pensions of the Senate and

21 the Committee on Commerce of the House of Representa22 tives a report that describes the activities carried out

23 under this section.

24 ‘‘(e) SUPPLEMENT NOT SUPPLANT.—Funds appro25 priated under this section shall be used to supplement and
9

•S 2731 IS

1 not supplant other Federal, State, and local public funds

2 provided for activities under this section.

3 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There

4 is authorized to be appropriated to carry out this section

5 such sums as may be necessary for each of the fiscal years

6 2001 through 2006.

7 ‘‘SEC. 319D. REVITALIZING THE CENTERS FOR DISEASE

8 CONTROL AND PREVENTION.

9 ‘‘(a) FINDINGS.—Congress finds that the Centers for

10 Disease Control and Prevention have an essential role in

11 defending against and combatting public health threats of

12 the twenty-first century and requires secure and modern

13 facilities that are sufficient to enable such Centers to con14 duct this important mission.

15 ‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—For the

16 purposes of achieving the mission of the Centers for Dis17 ease Control and Prevention described in subsection (a),

18 for constructing new facilities and renovating existing fa19 cilities of such Centers, including laboratories, laboratory

20 support buildings, health communication facilities, office

21 buildings and other facilities and infrastructure, for better

22 conducting the capacities described in section 319A, and

23 for supporting related public health activities, there are

24 authorized to be appropriated such sums as may be nec25 essary for each of fiscal years 2001 through 2010.
10

•S 2731 IS

1 ‘‘SEC. 319E. COMBATING ANTIMICROBIAL RESISTANCE.

2 ‘‘(a) TASK FORCE.—

3 ‘‘(1) IN GENERAL.—The Secretary shall estab4 lish an Antimicrobial Resistance Task Force to co5 ordinate Federal programs relating to antimicrobial

6 resistance. The Secretary may appoint or select a

7 committee, or other organization in existence as of

8 the date of enactment of this section, to serve as

9 such a task force, if such committee, or other orga10 nization meets the requirements of this section.

11 ‘‘(2) MEMBERS OF TASK FORCE.—The task

12 force described in paragraph (1) shall be composed

13 of representatives from such Federal agencies, public

14 health constituencies, manufacturers, medical profes15 sional societies and others as determined to be nec16 essary by the Secretary, to develop and implement a

17 comprehensive strategic plan to address the public

18 health threat of antimicrobial resistance.

19 ‘‘(3) AGENDA.—

20 ‘‘(A) IN GENERAL.—The task force de21 scribed in paragraph (1) shall consider factors

22 the Secretary considers appropriate,

23 including—

24 ‘‘(i) public health factors contributing

25 to increasing antimicrobial resistance;
11

•S 2731 IS

1 ‘‘(ii) public health needs to detect and

2 monitor antimicrobial resistance;

3 ‘‘(iii) detection, prevention, and con4 trol strategies for resistant pathogens;

5 ‘‘(iv) the need for improved informa6 tion and data collection;

7 ‘‘(v) the assessment of the risk im8 posed by pathogens presenting a threat to

9 the public health; and

10 ‘‘(vi) any other issues which the Sec11 retary determines are relevant to anti12 microbial resistance.

13 ‘‘(B) DETECTION AND CONTROL.—The

14 Secretary, in consultation with the task force

15 described in paragraph (1) and State and local

16 public health officials, shall—

17 ‘‘(i) develop, improve, coordinate or

18 enhance participation in a surveillance plan

19 to detect and monitor emerging anti20 microbial resistance; and

21 ‘‘(ii) develop, improve, coordinate or

22 enhance participation in an integrated in23 formation system to assimilate, analyze,

24 and exchange antimicrobial resistance data

25 between public health departments.
12

•S 2731 IS

1 ‘‘(4) MEETINGS.—The task force described

2 under paragraph (1) shall convene not less than

3 twice a year, or more frequently as the Secretary de4 termines to be appropriate.

5 ‘‘(b) RESEARCH AND DEVELOPMENT OF NEW ANTI6 MICROBIAL DRUGS AND DIAGNOSTICS.—The Director of

7 National Institute of Health and the Director of the Cen8 ter for Disease Control and Prevention, in collaboration

9 with members of the task force established under sub10 section (a), shall conduct and support research, investiga11 tions, experiments, demonstrations, and studies in the

12 health sciences that are related to—

13 ‘‘(1) the development of new therapeutics, in14 cluding vaccines and antimicrobials, against resist15 ant pathogens;

16 ‘‘(2) the development or testing of medical

17 diagnostics to detect pathogens resistant to

18 antimicrobials;

19 ‘‘(3) the epidemiology, mechanisms, and patho20 genesis of antimicrobial resistance;

21 ‘‘(4) the sequencing of the genomes of priority

22 pathogens as determined by the Director of the Na23 tional Institutes of Health in consultation with the

24 task force established under subsection (a); and

25 ‘‘(5) other relevant research areas.
13

•S 2731 IS

1 ‘‘(c) EDUCATION OF MEDICAL AND PUBLIC HEALTH

2 PERSONNEL.—The Secretary, after consultation with the

3 Surgeon General, the Director of the Centers for Disease

4 Control and Prevention, the Director of Health Resources

5 and Services Administration, the Director of the Agency

6 for Healthcare Research and Quality, members of the task

7 force described in subsection (a), and professional organi8 zations and societies, shall—

9 ‘‘(1) develop and implement educational pro10 grams to increase the awareness of the general pub11 lic with respect to the public health threat of anti12 microbial resistance and the appropriate use of anti13 biotics;

14 ‘‘(2) develop and implement educational pro15 grams to instruct health care professionals in the

16 prudent use of antibiotics; and

17 ‘‘(3) develop and implement programs to train

18 laboratory personnel in the recognition or identifica19 tion of resistance in pathogens.

20 ‘‘(d) GRANTS.—

21 ‘‘(1) IN GENERAL.—The Secretary shall award

22 competitive grants to eligible entities to enable such

23 entities to increase the capacity to detect, monitor,

24 and combat antimicrobial resistance.
14

•S 2731 IS

1 ‘‘(2) ELIGIBLE ENTITIES.—Eligible entities for

2 grants under paragraph (1) shall be State or local

3 public health agencies.

4 ‘‘(3) USE OF FUNDS.—An eligible entity receiv5 ing a grant under paragraph (1) shall use funds

6 from such grant for activities that are consistent

7 with the factors identified by the task force under

8 subsection (a)(3), which may include activities

9 that—

10 ‘‘(A) provide training to enable such entity

11 to identify patterns of resistance rapidly and

12 accurately;

13 ‘‘(B) develop, improve, coordinate or en14 hance participation in information systems by

15 which data on resistant infections can be shared

16 rapidly among relevant national, State, and

17 local health agencies and health care providers;

18 and

19 ‘‘(C) develop and implement policies to

20 control the spread of antimicrobial resistance.

21 ‘‘(e) GRANTS FOR DEMONSTRATION PROGRAMS.—

22 ‘‘(1) IN GENERAL.—The Secretary shall award

23 competitive grants to eligible entities to establish

24 demonstration programs to promote judicious use of
15

•S 2731 IS

1 antimicrobial drugs or control the spread of anti2 microbial-resistant pathogens.

3 ‘‘(2) ELIGIBLE ENTITIES.—Eligible entities for

4 grants under paragraph (1) may include hospitals,

5 clinics, institutions of long-term care, or professional

6 medical societies.

7 ‘‘(3) TECHNICAL ASSISTANCE.—The Secretary

8 shall provide appropriate technical assistance to eli9 gible entities that receive grants under paragraph

10 (1).

11 ‘‘(f) SUPPLEMENT NOT SUPPLANT.—Funds appro12 priated under this section shall be used to supplement and

13 not supplant other Federal, State, and local public funds

14 provided for activities under this section.

15 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There

16 are authorized to be appropriated to carry out this section,

17 such sums as may be necessary for each of the fiscal years

18 2001 through 2006.

19 ‘‘SEC. 319F. PUBLIC HEALTH COUNTERMEASURES TO A BIO20 TERRORIST ATTACK.

21 ‘‘(a) WORKING GROUP ON PREPAREDNESS FOR ACTS

22 OF BIOTERRORISM.—The Secretary, in coordination with

23 the Secretary of Defense, shall establish a joint inter24 departmental working group on preparedness and readi25 ness for the medical and public health effects of a bioter-
16

•S 2731 IS

1 rorist attack on the civilian population. Such joint working

2 group shall—

3 ‘‘(1) coordinate research on pathogens likely to

4 be used in a bioterrorist attack on the civilian popu5 lation as well as therapies to treat such pathogens;

6 ‘‘(2) coordinate research and development into

7 equipment to detect pathogens likely to be used in

8 a bioterrorist attack on the civilian population and

9 protect against infection from such pathogens;

10 ‘‘(3) develop shared standards for equipment to

11 detect and to protect against infection from patho12 gens likely to be used in a bioterrorist attack on the

13 civilian population; and

14 ‘‘(4) coordinate the development, maintenance,

15 and procedures for the release of, strategic reserves

16 of vaccines, drugs, and medical supplies which may

17 be needed rapidly after a bioterrorist attack upon

18 the civilian population.

19 ‘‘(b) WORKING GROUP ON THE PUBLIC HEALTH AND

20 MEDICAL CONSEQUENCES OF BIOTERRORISM.—

21 ‘‘(1) IN GENERAL.—The Secretary, in collabo22 ration with the Director of the Federal Emergency

23 Management Agency and the Attorney General, shall

24 establish a joint interdepartmental working group to
17

•S 2731 IS

1 address the public health and medical consequences

2 of a bioterrorist attack on the civilian population.

3 ‘‘(2) FUNCTIONS.—Such working group shall—

4 ‘‘(A) assess the priorities for and enhance

5 the preparedness of public health institutions,

6 providers of medical care, and other emergency

7 service personnel to detect, diagnose, and re8 spond to a bioterrorist attack; and

9 ‘‘(B) in the recognition that medical and

10 public health professionals are likely to provide

11 much of the first response to such an attack,

12 develop, coordinate, enhance, and assure the

13 quality of joint planning and training programs

14 that address the public health and medical con15 sequences of a bioterrorist attack on the civilian

16 population between—

17 ‘‘(i) local firefighters, ambulance per18 sonnel, police and public security officers,

19 or other emergency response personnel;

20 and

21 ‘‘(ii) hospitals, primary care facilities,

22 or public health agencies.

23 ‘‘(3) WORKING GROUP MEMBERSHIP.—In estab24 lishing such working group, the Secretary shall act

25 through the Director of the Office of Emergency
18

•S 2731 IS

1 Preparedness and the Director of the Centers for

2 Disease Control and Prevention.

3 ‘‘(4) COORDINATION.—The Secretary shall en4 sure coordination and communication between the

5 working groups established in this subsection and

6 subsection (a).

7 ‘‘(c) GRANTS.—

8 ‘‘(1) IN GENERAL.—The Secretary, in coordina9 tion with the working group established under sub10 section (b), shall award grants on a competitive

11 basis to eligible entities to enable such entities to in12 crease their capacity to detect, diagnose, and re13 spond to acts of bioterrorism upon the civilian popu14 lation.

15 ‘‘(2) ELIGIBILITY.—To be an eligible entity

16 under this subsection, such entity must be a State,

17 political subdivision of a State, consortium of 2 or

18 more States or political subdivisions of States, or a

19 hospital, clinic, or primary care facility.

20 ‘‘(3) USE OF FUNDS.—An entity that receives

21 a grant under this subsection shall use such funds

22 for activities that are consistent with the priorities

23 identified by the working group under subsection

24 (b), including—
19

•S 2731 IS

1 ‘‘(A) training health care professionals and

2 public health personnel to enhance the ability of

3 such personnel to recognize the symptoms and

4 epidemiological characteristics of exposure to a

5 potential bioweapon;

6 ‘‘(B) addressing rapid and accurate identi7 fication of potential bioweapons;

8 ‘‘(C) coordinating medical care for individ9 uals exposed to bioweapons; and

10 ‘‘(D) facilitating and coordinating rapid

11 communication of data generated from a bioter12 rorist attack between national, State, and local

13 health agencies.

14 ‘‘(4) COORDINATION.—The Secretary, in award15 ing grants under this subsection, shall—

16 ‘‘(A) notify the Director of the Office of

17 Justice Programs, and the Director of the Na18 tional Domestic Preparedness Office annually

19 as to the amount and status of grants awarded

20 under this subsection; and

21 ‘‘(B) coordinate grants awarded under this

22 subsection with grants awarded by the Office of

23 Emergency Preparedness and the Centers for

24 Disease Control and Prevention for the purpose

25 of improving the capacity of health care pro-
20

•S 2731 IS

1 viders and public health agencies to respond to

2 bioterrorist attacks on the civilian population.

3 ‘‘(5) ACTIVITIES.—An entity that receives a

4 grant under this subsection shall, to the greatest ex5 tent practicable, coordinate activities carried out

6 with such funds with the activities of a local Metro7 politan Medical Response System.

8 ‘‘(d) FEDERAL ASSISTANCE.—The Secretary shall

9 ensure that the Department of Health and Human Serv10 ices is able to provide such assistance as may be needed

11 to State and local health agencies to enable such agencies

12 to respond effectively to bioterrorist attacks.

13 ‘‘(e) EDUCATION.—The Secretary, in collaboration

14 with members of the working group described in sub15 section (b), and professional organizations and societies,

16 shall—

17 ‘‘(1) develop and implement educational pro18 grams to instruct public health officials, medical

19 professionals, and other personnel working in health

20 care facilities in the recognition and care of victims

21 of a bioterrorist attack; and

22 ‘‘(2) develop and implement programs to train

23 laboratory personnel in the recognition and identi24 fication of a potential bioweapon.
21

•S 2731 IS

1 ‘‘(f) FUTURE RESOURCE DEVELOPMENT.—The Di2 rector of National Institutes of Health and the Director

3 of the Centers for Disease Control and Prevention shall

4 consult with the working group described in subsection

5 (a), to develop priorities for and conduct research, inves6 tigations, experiments, demonstrations, and studies in the

7 health sciences related to—

8 ‘‘(1) the epidemiology and pathogenesis of po9 tential bioweapons;

10 ‘‘(2) the development of new vaccines or other

11 therapeutics against pathogens likely to be used in

12 a bioterrorist attack;

13 ‘‘(3) the development of medical diagnostics to

14 detect potential bioweapons; and

15 ‘‘(4) other relevant research areas.

16 ‘‘(g) REPORT.—Not later than 180 days after the

17 date of enactment of this section, and annually, on June

18 30 of each year thereafter, the Secretary shall prepare and

19 submit to the Committee on Health, Education, Labor,

20 and Pensions of the Senate, the Committee on Commerce

21 of the House of Representatives, the Committee on Armed

22 Services of the Senate, the Committee on Armed Services

23 of the House of Representatives, and other congressional

24 committees as may be appropriate, a report that—
22

•S 2731 IS

1 ‘‘(1) details the activities carried out by the

2 working groups under subsections (a) and (b) during

3 the fiscal year preceding the date on which the re4 port is submitted and describing such activities to be

5 undertaken by Federal agencies to combat bioter6 rorism in the subsequent year;

7 ‘‘(2) describes the programs carried out under

8 subsection (c); and

9 ‘‘(3) describes activities carried out by the Sec10 retary under subsections (d) and (e).

11 ‘‘(h) GENERAL ACCOUNTING OFFICE REPORT.—Not

12 later than 180 days after the date of enactment of this

13 section, the Comptroller General shall submit to the Com14 mittee on Health, Education, Labor, and Pensions of the

15 Senate and the Committee on Commerce of the House of

16 Representatives a report that describes—

17 ‘‘(1) Federal activities primarily related to re18 search on, preparedness for, and the management of

19 the public health and medical consequences of a bio20 terrorist attack against the civilian population;

21 ‘‘(2) the coordination of the activities described

22 in paragraph (1);

23 ‘‘(3) the amount of Federal funds authorized or

24 appropriated for the activities described in para25 graph (1); and
23

•S 2731 IS

1 ‘‘(4) the effectiveness of such efforts in pre2 paring national, State, and local authorities to ad3 dress the public health and medical consequences of

4 a potential bioterrorist attack against the civilian

5 population.

6 ‘‘(i) SUPPLEMENT NOT SUPPLANT.—Funds appro7 priated under this section shall be used to supplement and

8 not supplant other Federal, State, and local public funds

9 provided for activities under this section.

10 ‘‘(j) AUTHORIZATION OF APPROPRIATIONS.—There

11 is authorized to be appropriated to carry out this section

12 such sums as may be necessary for each of the fiscal years

13 2001 through 2006.’’.

Æ